Filtered By:
Source: Heart Rhythm

This page shows you your search results in order of relevance. This is page number 5.

Order by Relevance | Date

Total 406 results found since Jan 2013.

A New Model to Predict Ischemic Stroke in Patients with Atrial Fibrillation Using Warfarin or Direct Oral Anticoagulants
Stroke risk stratification scores (e.g., CHA2DS2-VASc) are used to tailor therapeutic recommendations for patients with atrial fibrillation (AF) in different risk groups.
Source: Heart Rhythm - December 11, 2018 Category: Cardiology Authors: J ’Neka S. Claxton, Richard F. MacLehose, Pamela L. Lutsey, Faye L. Norby, Lin Y. Chen, Wesley T. O’Neal, Alanna M. Chamberlain, Lindsay G.S Bengtson, Alvaro Alonso Source Type: research

Refining the Prediction of Stroke in Atrial Fibrillation. An elusive endeavor
Atrial fibrillation (AF), the most common sustained arrhythmia, is responsible for>20% of all strokes.1 AF-associated strokes are more severe, causing significantly greater long-term disability, accounting for greater resource utilization, and result in significantly higher mortality when compared to non-AF strokes.2-4 Oral anticoagulants (OACs) are the standard of care for the prevention of AF-associated stroke and systemic thromboembolism. To date OACs are the only therapeutic intervention that has been consistently and definitively shown to improve survival in the AF population.
Source: Heart Rhythm - December 18, 2018 Category: Cardiology Authors: Jason G. Andrade, Laurent Macle Source Type: research

Refining the prediction of stroke in atrial fibrillation: An elusive endeavor
Atrial fibrillation (AF), the most common sustained arrhythmia, is responsible for>20% of all strokes.1 AF-associated strokes are more severe, causing significantly greater long-term disability, accounting for greater resource utilization, and resulting in significantly higher mortality compared to non-AF strokes.2 –4 Oral anticoagulants (OACs) are the standard of care for the prevention of AF-associated stroke and systemic thromboembolism. To date, OACs are the only therapeutic intervention that has been consistently and definitively shown to improve survival in the AF population.
Source: Heart Rhythm - December 18, 2018 Category: Cardiology Authors: Jason G. Andrade, Laurent Macle Tags: Editorial Commentary Source Type: research

Left Atrial Appendage Closure Device Implantation in Patients at Very High Risk for Stroke
Little is known about the role of left atrial appendage closure using Watchman ™ device in patients who are at very high risk for stroke.
Source: Heart Rhythm - July 11, 2019 Category: Cardiology Authors: Erika Hutt, Oussama M. Wazni, Simrat Kaur, Walid I. Saliba, Khaldoun G. Tarakji, Samir Kapadia, Jose Aguilera, Amr F. Barakat, Mouin Abdallah, Wael Jaber, Peter Rasmussen, Shazam Hussain, Ken Uchino, Dolora Wisco, Bruce D. Lindsay, Mohamed Kanj, Ayman A. Source Type: research

Impact of atrial fibrillation/flutter on the in-hospital mortality of ischemic stroke patients
Stroke is the second leading cause of death worldwide. Ischemic strokes, which are caused by atrial fibrillation/flutter (AF) may be more devastating than those without AF.
Source: Heart Rhythm - October 3, 2019 Category: Cardiology Authors: Karsten Keller, Lukas Hobohm, Philip Wenzel, Thomas M ünzel, Christine Espinola-Klein, Mir A. Ostad Source Type: research

The Decrease in Peak Atrial Longitudinal Strain in Patients with Atrial Fibrillation as a Practical Parameter for Stroke Risk Stratification
Decreased peak atrial longitudinal strain (LA strain) derived from two-dimensional speckle tracking is frequently observed in patients with atrial fibrillation (AF) and associated with the risk of ischemic stroke.
Source: Heart Rhythm - December 28, 2020 Category: Cardiology Authors: Jo-Nan Liao, Tze-Fan Chao, Chung-Lieh Hung, Shih-Ann Chen Source Type: research

Predictors of ischemic stroke for low-risk patients with atrial fibrillation: A matched case-control study
The predictors of ischemic stroke in ‘low-risk’ patients with atrial fibrillation (AF) (CHA2DS2-VASc score 0 in men or 1 in women) are debated.
Source: Heart Rhythm - January 19, 2021 Category: Cardiology Authors: Soonil Kwon, Tae Jung Kim, Eue-Keun Choi, Hyo-Jeong Ahn, Euijae Lee, So-Ryoung Lee, Sang-Bae Ko, Seil Oh, Gregory Y.H. Lip Source Type: research

Racial Differences in Incidence of Atrial Fibrillation after Cryptogenic Stroke
The incidence of atrial fibrillation (AF) is lower among non-whites compared to whites, despite a higher burden of AF risk factors. The incidence of new AF after cryptogenic stroke among minorities, however, is unknown.
Source: Heart Rhythm - January 29, 2021 Category: Cardiology Authors: David B. Laslett, Abdullah Haddad, Hardik Mangrolia, Dianna Gaballa, Olivia Follis, Chethan Gangireddy, Anuj Basil, Richard Greenberg, George Yesenosky, Edmond Cronin, Joshua Cooper, Isaac R. Whitman Source Type: research

Blood biomarkers to detect new-onset atrial fibrillation and cardioembolism in ischemic stroke patients
Accumulating data suggest blood biomarkers could inform stroke etiology.
Source: Heart Rhythm - February 6, 2021 Category: Cardiology Authors: Dorin Harpaz, Ram Bajpai, Geelyn J.L. Ng, Michael Soljak, Robert S. Marks, Christine Cheung, Thiruma Valavan Arumugam, Amy M.L. Quek, Alfred I.Y. Tok, Raymond C.S. Seet Source Type: research

Racial differences in the incidence of atrial fibrillation after cryptogenic stroke
The incidence of atrial fibrillation (AF) is lower in nonwhites than in whites despite a higher burden of AF risk factors. However, the incidence of new AF after cryptogenic stroke in minorities is unknown.
Source: Heart Rhythm - January 29, 2021 Category: Cardiology Authors: David B. Laslett, Abdullah Haddad, Hardik Mangrolia, Dianna Gaballa, Olivia Follis, Chethan Gangireddy, Anuj Basil, Richard Greenberg, George Yesenosky, Edmond Cronin, Joshua Cooper, Isaac R. Whitman Source Type: research

B-po05-199 differences in stroke or systemic thromboembolism readmissions after hospitalization for atrial fibrillation or atrial flutter
Although atrial fibrillation (AF) and atrial flutter (AFL) are different arrhythmias, they are assumed to confer the same risk of stroke and systemic thromboembolism (STE) despite a lack of available evidence.
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Harshith Thyagaturu, Alexander Bolton, Sittinun Thangjui, Dinesh Voruganti, Hakan Paydak Source Type: research

B-po05-144 comparing sodium glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset atrial fibrillation and ischemic stroke
Given the susceptibility of patients with type 2 diabetes mellitus towards cerebrovascular complications, there is increasing research on the cerebrovascular-protective effects of novel anti-diabetic agents. However, few studies have compared sodium glucose cotransporter-2 inhibitor (SGLT2I) and dipeptidyl peptidase-4 inhibitor (DPP4I) in their effects on stroke and atrial fibrillation (AF).
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Sharen Lee, Jiandong Zhou, Xiansong Wang, Carlin Chang, Tong Liu, Dong Chang, Wing Tak Wong, William K.K. Wu, Bernard M.Y. Cheung, Gary Tse, Qingpeng Zhang Source Type: research

B-po04-162 risk of recurrent stroke with runs of supraventricular tachycardia and premature atrial contraction burden
Ischemic strokes are a significant cause of mortality in the United States, leading to roughly 140,000 deaths per year. Approximately one third are classified as cryptogenic. Previous studies have shown premature atrial contractions (PAC) and short runs of supraventricular tachycardia (SVT) increase the risk of stroke.
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Weston Harkness, Jeff M. Hsing, Julie Davidson Source Type: research

B-po04-147 trends in early stroke and mortality in epicardial versus endocardial left atrial appendage closure in atrial fibrillation: nationwide readmissions database 2016-2018
Percutaneous left atrial appendage closure (LAAC) devices have emerged as an important alternative to anticoagulation for stroke prevention in patients with atrial fibrillation. National data on recent trends and early complication rates associated with endocardial (endo) LAAC and epicardial (epi) LAAC procedures are limited.
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Edward V. Kogan, Christopher F. Liu, Shing C. Wong, Geoffrey W. Bergman, James E. Ip, George Thomas, Steven M. Markowitz, Bruce B. Lerman, Luke Kim, Jim W. Cheung Source Type: research

B-po04-115 hypertension and abnormal renal function increased the risk of ischemic stroke in anticoagulated ehra type-1 valvular atrial fibrillation
Atrial fibrillation (AF) increases the risk of stroke substantially, therefore many scores have been developed to risk stratify these patients. However, most of the previous studies have focused on non-valvular AF. The most widely used risk stratification score is the CHA2DS2-VASC score. Unfortunately, the validation of this score in valvular AF is poor.
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Rena Winanti, Sunu Budhi Raharjo, Rina Ariani, Dicky A. Hanafy, Celly Anantaria Atmadikoesoemah, Prima Almazini, Yoga Yuniadi Source Type: research